Dyax Corp. Registered Direct Offering
Our Business Law lawyers represented Dyax Corp. in its $30,000,000 registered direct offering (RDO) to existing institutional investors. Dyax Corp. is a biopharmaceutical company based in Burlington, Massachusetts, which invented, developed and sells KALBITOR for the treatment of hereditary angiodema (HAE).
Posted on May 16, 2013
RELATED PROFESSIONALS
RELATED SERVICES
INDUSTRIES
PRACTICES
Disclaimer
Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.